New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
14:25 EDTBA, BA, LLY, LLYSenate Judiciary Committee to hold a hearing
The Subcommittee on Crime and Terrorism holds a hearing entitled, "Economic Espionage and Trade Secret Theft: Are Our Laws Adequate for Today’s Threats? with Vice President Paul Hoffman of The Boeing Company and Vice President Doug Norman of Eli Lilly & Company on May 13 at 2:30 pm. Webcast Link
News For BA;LLY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 20, 2015
08:01 EDTLLYEli Lilly and Innovent Biologics announce strategic alliance
Subscribe for More Information
07:41 EDTLLYAmerican Academy of Dermatology to hold annual meeting
Subscribe for More Information
March 19, 2015
08:08 EDTLLYEli Lilly and Hanmi sign license and collaboration agreement
Subscribe for More Information
06:33 EDTBAAir Lease leases two Boeing 777-300ERs with Air Austral
Subscribe for More Information
06:20 EDTBACytec Industries upgraded to Buy from Neutral at Citigroup
Subscribe for More Information
March 18, 2015
14:10 EDTBABoeing, Airbus stepping pressure on supllier over seat delays, Reuters says
Subscribe for More Information
12:48 EDTLLYFly Watch: Biogen predicted to report strong Alzheimer's data this Friday
Subscribe for More Information
12:01 EDTBABoeing 747-8 Intercontinental receives FAA approval for 330-minute ETOPS
Subscribe for More Information
09:35 EDTBAFedEx says not defering plane deliveries due to low fuel costs
Subscribe for More Information
07:46 EDTLLYLilly Roche would have upbeat read through from strong BIIB data, says Bernstein
Bernstein notes that the data for Biogen's (BIIB) Alzheimer's treatment, due to be released on Friday, is widely expected to be positive. The firm thinks that positive data would boost the outlook for similar Alzheimer's drugs being developed by Eli Lilly (LLY) and Roche (RHHBY), since consensus estimates for those drugs are low. The firm keeps Outperform ratings on Eli Lilly and Roche.
06:38 EDTBABoeing looking to potential Malaysia deal to boost fighter jets, Reuters says
Subscribe for More Information
06:36 EDTBABoeing turns to cargo jets to overcome West coast port disruptions, WSJ says
Boeing (GE) and its suppliers -- including General Electric (GE) -- have turned to using large Ukrainian "Antonov" cargo jets to overcome supply disruptions at U.S. West coast ports, reports the Wall Street Journal, citing statements by Boeing Commercial CEO Ray Conner, who said disruptions continued even after the ports reached a deal earlier in March. "We’re still dealing with the congestion of all the things that are stuck in those ports right now," added Conner. A Boeing spokesperson said there had been "no effect" on deliveries to airlines. Reference Link
March 17, 2015
09:06 EDTBABoeing delivers first 787-9 Dreamliner assembled at North Charleston facility
Subscribe for More Information
07:42 EDTBABoeing may produce satellite for tech giants, Reuters says
Subscribe for More Information
07:18 EDTBASatellite & Access Intelligence to hold a exhibition
Subscribe for More Information
March 16, 2015
13:37 EDTBABoeing responds to IAM's petition to unionize Boeing South Carolina
Boeing was notified that the International Association of Machinists union has petitioned the National Labor Relations Board for a union election at the company's North Charleston, S.C., facilities. If the NLRB permits it, a vote will be scheduled for eligible teammates to decide whether they will turn over their rights to the IAM or keep a direct relationship with the company. "Boeing South Carolina teammates have done what so many people said couldn't be done. And they did it by working together, engaging every day, and truly committing themselves to the success of our site," said Beverly Wyse, Boeing South Carolina's newly appointed vice president and general manager. "And let's be really clear, the IAM was not part of this success – it was our BSC teammates. In fact, the IAM aggressively opposed it, as publicly demonstrated by their filing of a claim with the National Labor Relations Board, to try to keep our site from even opening. Now, simply by filing this petition, the same union that tried to take our jobs and our work, has already begun to divide our team at a time when we're just beginning to gel and catch a solid rhythm in production." Boeing firmly believes that a union is not in the best interest of Boeing South Carolina teammates and their families, their communities, and the state of South Carolina, especially after years of the IAM insulting the abilities of Boeing South Carolina teammates and fighting against BSC's success. "We think our Boeing South Carolina teammates deserve to pave their own future and keep their hard-earned money in their own pockets," said Wyse. "In fact, they've been very successful doing just that for the past five years. They've built not only new airplanes, but also a new site, and new opportunities for an incredible future here in South Carolina by working together as a team, without the distractions of a union. We're extremely proud of what our teammates have accomplished." Boeing South Carolina has established several outlets to keep teammates, their families and the community updated throughout this process, including a website and Facebook page that provides information, facts, data, and additional resources related to the IAM's unionizing efforts in South Carolina.
10:00 EDTBARyanair plans transatlantic service in four to five years, Financial Times says
Subscribe for More Information
09:11 EDTBAViaSat and Boeing announce collaboration to offer broadband system
Subscribe for More Information
07:27 EDTLLYBiodel BIOD-961 Phase 1 clinical trial meets primary efficacy endpoint
Biodel (BIOD) announced positive preliminary results from Study 6-101, a Phase 1 clinical trial comparing Biodel's lyophilized glucagon formulation BIOD-961, designed for use in a proprietary Glucagon Emergency Management, or GEM, auto-reconstitution device, to Eli Lilly's (LLY) Glucagon Emergency Rescue Kit and Novo Nordisk's GlucaGen HypoKit, which are marketed for the treatment of severe hypoglycemia. Study 6-101 was a randomized, single-center, double blind, six-period cross over study in 15 healthy volunteers who received each glucagon administered subcutaneously, or SC, and intramuscularly, or IM, in a randomized treatment sequence. The objectives of the study were to compare the pharmacokinetic, or PK, profiles, the pharmacodynamic, or PD, glucose, responses, and the PK/PD relationships of IM and SC dosing, as well as to assess safety profiles of the three test glucagons. Study 6-101 was a Phase 1 randomized, single-center, double blind, six-period cross over study designed to evaluate the PK and PD profiles of BIOD-961 compared to marketed glucagon formulations manufactured by Eli Lilly and Novo Nordisk. BIOD-961 is a lyophilized glucagon formulation designed for use in the GEM auto-reconstitution device. On six separate dosing days, each subject received 1 mg of one of the test glucagons delivered either SC or IM. Fifteen normal, healthy subjects were randomized into the study and ten completed all dosings. The objectives of the study were to compare the PK profiles, the PD responses, and the PK/PD relationships of IM and SC dosing, as well as to assess safety profiles of the three test glucagons. These data will facilitate selection of an appropriate marketed glucagon to use as a comparator in the planned pivotal study, in which the primary efficacy endpoint for approval is to demonstrate PK and PD bioequivalence of BIOD-961 to one of the marketed comparators.
06:59 EDTBABoeing to hit 737 production targets by 2018, Reuters says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use